Page 217 - congress
P. 217

POSTER PRESENTATION / POSTER SUNUM



                    Pharmacological and Supplementary Agents Use in Aquarium Fish: Current Trends


                   Farah Gonul AYDIN¹                  Cemre CELEP *                       Suveyda PAK
                                                                     2,
                                                                                                         3


               ¹Ankara University, Faculty of Veterinary Medicine, Department of Veterinary Pharmacology
                                                  and Toxicology, TÜRKİYE
                  2 Ankara University, Graduate School of Health Sciences, Veterinary Pharmacology and
                                                    Toxicology, TÜRKİYE

                3 Ankara University, Graduate School of Health Sciences, Laboratory Animal Unit, TÜRKİYE


               *Correspound Author: cemrecelep90@gmail.com



                     Aquatic animals, particularly aquarium kept as pets, have gained increasing
               importance both in clinical veterinary medicine and in hobby aquaculture. Aquarium fish are
               kept in many households worldwide, with an estimated 139 million freshwater aquarium fish
               reportedly kept in homes across the United States alone.This widespread popularity presents
               clinical veterinarians with a diverse range of health problems. The spectrum of diseases
               extends from parasitic, bacterial, viral, and fungal infections to environmental stress factors,
               creating significant challenges in selecting appropriate therapeutic products. According to
               the literature, antibiotics, antiparasitic drugs, and anesthetic agents are among the most
               commonly used pharmacological products in clinical  practice.  While  some  of  these  are
               licensed specifically for fish species, a considerable proportion are derived from products
               originally developed for humans or other animals and are applied off-label in aquatic species.
               In addition, supportive  products such as vitamins, probiotics, and immunostimulants are
               frequently reported in both prophylactic and therapeutic contexts. Furthermore, the literature
               repeatedly emphasizes that treatments are often unsuccessful unless appropriate water
               quality is ensured. Thus, products that regulate water parameters—including pH stabilizers,
               ammonia binders, salt supplements, and disinfectants—play a critical role in clinical success,
               even though they are not directly pharmacological in nature. The present review aims to
               systematically summarize the literature on licensed and off-label pharmacological agents,
               as well as supportive and water quality–modifying products used in aquatic animals, thereby
               providing clinicians with a practical and updated reference. The poster presentation will
               highlight the growing  popularity of aquarium fish, the  therapeutic  challenges posed by
               disease diversity, and the existing gaps in pharmacological applications, supported by visual
               and numerical data.

               Keywords:  Aquatic animals,  aquatic pharmacology,  extra-label use,  ornamental fish,
               therapeutics.


                                                                                                          214
   212   213   214   215   216   217   218   219   220   221   222